Cargando…
Will the epidemic of metabolic syndrome raise the prevalence of antiplatelet drug resistance?
Autores principales: | Kones, Richard, Rumana, Umme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783671/ https://www.ncbi.nlm.nih.gov/pubmed/24083139 http://dx.doi.org/10.4103/2229-516X.117047 |
Ejemplares similares
-
A General Pathway Model for Improving Health Disparities: Lessons from Community and Cultural Involvement in Improving Cervical Cancer Screening in Vietnamese Women
por: Kones, Richard, et al.
Publicado: (2019) -
Trends in Guideline-Driven Revascularization in Diabetic Patients with Multivessel Coronary Heart Disease
por: Rumana, Umme, et al.
Publicado: (2019) -
Antiplatelet Drugs and Endothelial Function
por: Higashi, Yukihito
Publicado: (2016) -
Antiplatelet therapy for elderly patients with Acute Coronary Syndromes
por: Savonitto, Stefano, et al.
Publicado: (2018) -
Persistent organic pollutants and epidemic of diabetes and metabolic syndrome
por: Lee, Hong Kyu
Publicado: (2010)